Tag: COVID-19

May 7, 2021

The Biden-Harris Administration is backing a proposal from the World Trade Organization (WTO), supported by South Africa and India, that would temporarily remove IP protections on COVID-19 vaccines. The move itself is surprising, given that historically the US has been […]

April 30, 2021

University of Tokyo researchers and colleagues at the RIKEN Research Institute have compiled a first-of-its-kind genetic database for autoimmune and autoinflammatory diseases. It’s hoped that the resource will offer up new insights into how immune disorders develop, and potentially aid […]

April 28, 2021

We are seeing incredible progress in the roll-out of Covid-19 vaccines. We are on track for all adults in the UK to have been offered the vaccine by July. Researchers and healthcare workers are rightfully being celebrated for all their […]

April 14, 2021

The sheer speed of developing and gaining regulatory approval for effective vaccines against Covid-19 has been unprecedented. Transporting them rapidly and safely from manufacturing sites to vaccination centres and doctors’ surgeries across the world is possibly the biggest challenge the […]

April 12, 2021

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases, today announced the U.S. Food and Drug Administration (FDA) has accepted its Investigational […]

April 5, 2021

Emergent BioSolutions Inc. (NYSE:EBS) today announced that the Company continues to be on track with its manufacturing agreements related to COVID-19 vaccines and confirmed that there are no changes to its financial guidance for 2021. In addition, the Company received […]

April 2, 2021

COVID-19 is a pneumonic disease that is caused by SARS-Cov2 virus. Previous ancestors of COVID-19 virus are SARS-CoV and MERS Virus. Loss of few base pairs has led to the mutation in the genetic material of SARS-CoV2. High multiplication rate […]

March 17, 2021

Tonix Pharmaceuticals, Inc.. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced preliminary results following vaccination of non-human primates with TNX-1800 (modified horsepox virus, live vaccine), a live attenuated COVID-19 vaccine candidate engineered to express the SARS-CoV-2 […]

March 15, 2021

Six members of the European Union have raised concerns over how the bloc is distributing Covid-19 vaccines, after AstraZeneca cut its delivery targets once again. Austria, Latvia, the Czech Republic, Bulgaria, Croatia and Slovenia wrote to the European Commission on […]

March 10, 2021

The European Union and the United Kingdom have clashed over the export of coronavirus vaccines, with Britain fiercely denying it has blocked any shipments to other nations. The latest battle emerged after European Council President Charles Michel accused the U.K. […]

February 11, 2021

Eurofins launches a new CE marked serological assay for the identification and quantification of antibodies to SARS-CoV-2. This ELISA kit can support vaccination campaigns by confirming the success of a vaccination and monitoring the antibody levels over time. Vaccination against […]

February 10, 2021

The FDA last night granted Emergency Use Authorization (EUA) for a 700 mg dose of bamlanivimab (LY-CoV555) in combination with a 1400 mg dose of a second Lilly antibody candidate, etesevimab (LY-CoV016), for the treatment of mild to moderate COVID-19 […]